Emerging therapeutic strategies for unmet need in neovascular age-related macular degeneration

Emerging therapeutic strategies for unmet need in neovascular age-related macular degeneration

Abstract Neovascular age-related macular degeneration (nAMD) is a major cause of visual impairment and blindness. Anti-vascular endothelial growth factor (VEGF) agents, such as ranibizumab, bevacizumab, aflibercept, brolucizumab and faricimab have revolutionized the clinical management of nAMD. Howe...

Full description

Bibliographic Details
Main Authors: Levon M. Khachigian, Gerald Liew, Kelvin Y. C. Teo, Tien Y. Wong, Paul Mitchell
Format: Article
Language:English
Published: BMC 2023-02-01
Series:Journal of Translational Medicine
Subjects:
Neovascular age-related macular degeneration
Vascular endothelial growth factor
VEGF receptors
Anti-VEGF therapy
Aflibercept
Ranibizumab
Online Access:https://doi.org/10.1186/s12967-023-03937-7

Internet

https://doi.org/10.1186/s12967-023-03937-7

Similar Items